Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04634877
PHASE3

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to disease-free survival (DFS) as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to overall survival (OS). The primary hypotheses are that pembrolizumab + adjuvant chemotherapy is superior to placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to DFS as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to OS.

Official title: A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

990

Start Date

2021-01-10

Completion Date

2026-09-15

Last Updated

2025-06-09

Healthy Volunteers

No

Interventions

BIOLOGICAL

Pembrolizumab

IV infusion

DRUG

Carboplatin

IV infusion

DRUG

Paclitaxel

IV infusion

DRUG

Placebo for pembrolizumab

IV infusion

DRUG

Docetaxel

IV infusion docetaxel 75 mg/m\^2 Q3W or 25 mg/m2 QW may be given in place of paclitaxel following sponsor consultation if a participant experiences severe hypersensitivity to paclitaxel or an adverse event requiring discontinuation of paclitaxel.

DRUG

Cisplatin

Cisplatin 75 mg/m\^2 IV infusion Q3W may be given in place of carboplatin following sponsor consultation if a participant experiences severe hypersensitivity to carboplatin or an adverse event requiring discontinuation of carboplatin.

RADIATION

External Beam Radiotherapy (EBRT)

≥4500 cGY given according to local practice, at the discretion of the investigator

DRUG

Cisplatin (as radiosensitizer)

If a participant receives external beam radiotherapy (EBRT), then cisplatin 50 mg/m\^2 IV infusion may be administered as a radiosensitizer at the discretion of the investigator, on days 1 and 29

RADIATION

Brachytherapy

Given according to local practice, at the discretion of the investigator

Locations (231)

University of Alabama - Birmingham ( Site 3061)

Birmingham, Alabama, United States

University of South Alabama, Mitchell Cancer Institute ( Site 3058)

Mobile, Alabama, United States

HonorHealth Research Institute - Biltmore ( Site 3043)

Phoenix, Arizona, United States

Arizona Oncology Associates PC- HOPE ( Site 3049)

Tucson, Arizona, United States

UCSD Moores Cancer Center ( Site 3053)

La Jolla, California, United States

University Of Colorado ( Site 3051)

Aurora, Colorado, United States

Smilow Cancer Hospital at Yale New Haven ( Site 3070)

New Haven, Connecticut, United States

Mount Sinai Cancer Center ( Site 3081)

Miami Beach, Florida, United States

Northside Hospital ( Site 3036)

Atlanta, Georgia, United States

Northwestern Memorial Hospital ( Site 3044)

Chicago, Illinois, United States

Parkview Cancer Institute ( Site 3067)

Fort Wayne, Indiana, United States

Indiana University Melvin and Bren Simon Cancer Center ( Site 3071)

Indianapolis, Indiana, United States

University of Iowa Hospital and Clinics ( Site 3046)

Iowa City, Iowa, United States

Norton Cancer Institute - St. Matthews ( Site 3056)

Louisville, Kentucky, United States

WK Physicians Network/Gynecologic Oncology Associates ( Site 3047)

Shreveport, Louisiana, United States

University of Massachusetts Medical School ( Site 3037)

Worcester, Massachusetts, United States

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 3076)

Mineola, New York, United States

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 3042)

New York, New York, United States

Montefiore Medical Center ( Site 3065)

The Bronx, New York, United States

Duke Cancer Center ( Site 3072)

Durham, North Carolina, United States

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 3080)

Fargo, North Dakota, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C

Columbus, Ohio, United States

Legacy Good Samaritan Medical Center ( Site 3033)

Portland, Oregon, United States

Sidney Kimmel Cancer Center - Jefferson Health ( Site 3078)

Philadelphia, Pennsylvania, United States

AHN West Penn Hospital ( Site 3060)

Pittsburgh, Pennsylvania, United States

Abington Hospital - Asplundh Cancer Center ( Site 3073)

Willow Grove, Pennsylvania, United States

Sanford Gynecology Oncology ( Site 3045)

Sioux Falls, South Dakota, United States

UT Southwestern Medical Center ( Site 3063)

Dallas, Texas, United States

VCU Massey Cancer Center ( Site 3068)

Richmond, Virginia, United States

Centro de Oncología e Investigación de Buenos Aires ( Site 1005)

Berazategui, Buenos Aires, Argentina

IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 1006)

Caba, Buenos Aires, Argentina

Instituto de Investigaciones Clinicas Mar del Plata ( Site 1003)

Mar del Plata, Buenos Aires, Argentina

Hospital Britanico de Buenos Aires ( Site 1002)

Buenos Aires, Buenos Aires F.D., Argentina

Instituto de Oncologia de Rosario ( Site 1004)

Rosario, Santa Fe Province, Argentina

IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 1010)

Buenos Aires, Argentina

Hospital Aleman ( Site 1001)

Buenos Aires, Argentina

CEMIC ( Site 1009)

Buenos Aires, Argentina

Centro Oncologico Riojano Integral ( Site 1007)

La Rioja, Argentina

Medizinische Universitat Graz ( Site 2004)

Graz, Styria, Austria

Medizinische Universitaet Innsbruck ( Site 2001)

Innsbruck, Tyrol, Austria

Saint-Luc UCL ( Site 2042)

Brussels, Bruxelles-Capitale, Region de, Belgium

C.I.U. Hopital Ambroise Pare ( Site 2039)

Mons, Hainaut, Belgium

CHR Verviers ( Site 2035)

Verviers, Liege, Belgium

OLV Ziekenhuis ( Site 2038)

Aalst, Oost-Vlaanderen, Belgium

AZ Maria Middelares Gent ( Site 2032)

Ghent, Oost-Vlaanderen, Belgium

Universitair Ziekenhuis Gent ( Site 2037)

Ghent, Oost-Vlaanderen, Belgium

AZ Nikolaas ( Site 2031)

Sint-Niklaas, Oost-Vlaanderen, Belgium

UZ Leuven ( Site 2040)

Leuven, Vlaams-Brabant, Belgium

AZ Groeninge ( Site 2036)

Kortrijk, West-Vlaanderen, Belgium

CHC - Groupe Sante ( Site 2041)

Liège, Belgium

CHU Liege Sart-Tilman ( Site 2044)

Liège, Belgium

Tom Baker Cancer Centre ( Site 3007)

Calgary, Alberta, Canada

Kingston Health Sciences Centre ( Site 3003)

Kingston, Ontario, Canada

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 3006)

Montreal, Quebec, Canada

McGill University Health Centre ( Site 3005)

Montreal, Quebec, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 3

Québec, Quebec, Canada

Fundacion Arturo Lopez Perez FALP ( Site 1062)

Santiago, Region M. de Santiago, Chile

Centro de Cancer Nuestra Senora de la Esperanza ( Site 1063)

Santiago, Region M. de Santiago, Chile

Bradfordhill-Clinical Area ( Site 1070)

Santiago, Region M. de Santiago, Chile

Centro Investigación del Cáncer James Lind ( Site 1061)

Temuco, Región de la Araucanía, Chile

Oncocentro ( Site 1065)

Viña del Mar, Región de Valparaíso, Chile

Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 4034)

Hefei, Anhui, China

Beijing Cancer Hospital ( Site 4048)

Beijing, Beijing Municipality, China

Peking Union Medical College Hospital ( Site 4036)

Beijing, Beijing Municipality, China

Chongqing Cancer Hospital ( Site 4040)

Chongqing, Chongqing Municipality, China

The First Affiliated Hospital of Xiamen University ( Site 4060)

Xiamen, Fujian, China

The First Affiliated Hospital ( Site 4043)

Guangzhou, Guangdong, China

Guangxi Medical University Affiliated Tumor Hospital ( Site 4049)

Nanning, Guangxi, China

Harbin Medical University Cancer Hospital ( Site 4033)

Harbin, Heilongjiang, China

Hubei Cancer Hospital ( Site 4059)

Wuhan, Hubei, China

Xiangya Hospital Central-South University ( Site 4035)

Changsha, Hunan, China

Hunan Cancer Hospital ( Site 4050)

Changsha, Hunan, China

Nanjing Drum Tower Hospital ( Site 4037)

Nanjing, Jiangsu, China

Jiangxi Maternal and Child Health Hospital ( Site 4051)

Nanchang, Jiangxi, China

The First Bethune Hospital of Jilin University ( Site 4057)

Changchun, Jilin, China

The First Affiliated Hospital of Xi an Jiaotong University ( Site 4045)

Xi'an, Shaanxi, China

Obstetrics and Gynecology Hosp. Fudan University ( Site 4041)

Shanghai, Shanghai Municipality, China

Shanghai Renji Hospital Affiliated to Jiao Tong University ( Site 4053)

Shanghai, Shanghai Municipality, China

Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 4001)

Shanghai, Shanghai Municipality, China

Sichuan Cancer Hospital ( Site 4039)

Chengdu, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital ( Site 4054)

Tianjin, Tianjin Municipality, China

Yunnan Province Cancer Hospital-Gynecology Department ( Site 4055)

Kunming, Yunnan, China

The First Affiliated Hospital, Zhejiang University-Gynecology ( Site 4002)

Hangzhou, Zhejiang, China

Women s Hospital School of Medicine Zhejiang University ( Site 4032)

Hangzhou, Zhejiang, China

The First Affiliated Hospital of Wenzhou Medical University ( Site 4056)

Wenzhou, Zhejiang, China

Clínica Vida Fundación - Sede Poblado ( Site 1096)

Medellín, Antioquia, Colombia

Instituto Nacional de Cancerología E.S.E ( Site 1094)

Bogotá, Bogota D.C., Colombia

Instituto Cancerologico de Narino Ltda ( Site 1092)

Pasto, Departamento de Nariño, Colombia

Fundacion Valle del Lili ( Site 1093)

Cali, Valle del Cauca Department, Colombia

Fakultní nemocnice Brno Bohunice-Gynekologicko-porodnicka klinika ( Site 2394)

Brno, Brno-mesto, Czechia

Fakultni nemocnice Kralovske Vinohrady ( Site 2393)

Prague, Praha 10, Czechia

Vseobecna fakultni nemocnice v Praze ( Site 2391)

Prague, Praha 2, Czechia

Fakultni nemocnice Olomouc ( Site 2392)

Olomouc, Czechia

Rigshospitalet University Hospital ( Site 2515)

Copehagen, Capital Region, Denmark

Herlev Hospital ( Site 2514)

Herlev, Capital Region, Denmark

Aalborg Universitetshospital ( Site 2511)

Aalborg, North Denmark, Denmark

Roskilde Sygehus ( Site 2513)

Roskilde, Region Sjælland, Denmark

Odense Universitetshospital ( Site 2512)

Odense, Region Syddanmark, Denmark

Kuopio University Hospital ( Site 2543)

Kuopio, Northern Savonia, Finland

Tampere University Hospital ( Site 2541)

Tampere, Pirkanmaa, Finland

Turku University Hospital ( Site 2542)

Turku, Southwest Finland, Finland

Institut De Cancerologie De Lorraine ( Site 2072)

Vandœuvre-lès-Nancy, Ain, France

Centre Antoine Lacassagne ( Site 2073)

Nice, Alpes-Maritimes, France

Centre Francois Baclesse ( Site 2062)

Caen, Calvados, France

Hôpital Privé Des Côtes d'Armor ( Site 2063)

Plérin, Cotes-d Armor, France

CHU Besancon - Hopital Jean Minjoz ( Site 2068)

Besançon, Doubs, France

Institut Bergonie ( Site 2067)

Bordeaux, Gironde, France

Institut Universitaire du Cancer Toulouse - Oncopole ( Site 2065)

Toulouse, Haute-Garonne, France

Institut Regional du Cancer de Montpellier - ICM ( Site 2069)

Montpellier, Herault, France

Hopital prive du Confluent ( Site 2061)

Nantes, Loire-Atlantique, France

Centre Hospitalier Lyon Sud ( Site 2064)

Pierre-Bénite, Rhone, France

Hopital Cochin ( Site 2070)

Paris, Île-de-France Region, France

Gustave Roussy ( Site 2071)

Villejuif, Île-de-France Region, France

SLK-Kliniken Heilbronn GmbH ( Site 2116)

Heilbronn, Baden-Wurttemberg, Germany

Klinikum Ludwigsburg ( Site 2111)

Ludwigsburg, Baden-Wurttemberg, Germany

Universitaetsklinikum Tuebingen ( Site 2113)

Tübingen, Baden-Wurttemberg, Germany

Medizinische Hochschule Hannover-Department of Obstetrics and Gynecology ( Site 2109)

Hanover, Lower Saxony, Germany

Universitätsklinikum Bonn-Gynaecological oncology ( Site 2103)

Bonn, North Rhine-Westphalia, Germany

Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung ( Site 2105)

Essen, North Rhine-Westphalia, Germany

Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur

Dresden, Saxony, Germany

Universitätsklinikum Schleswig-Holstein ( Site 2101)

Lübeck, Schleswig-Holstein, Germany

General Hospital of Patras. St Andrews ( Site 2421)

Pátrai, Achaia, Greece

Geniko Panepistimako Nosokomeio ARETEIO ( Site 2423)

Athens, Attica, Greece

Perifereiako Geniko Nosokomeio ALEXANDRA ( Site 2425)

Athens, Attica, Greece

Athens University Hospital ATTIKON ( Site 2424)

Chaïdári, Attica, Greece

Hospital Hygeia ( Site 2426)

Marousi, Attica, Greece

Euromedica General Clinic of Thessaloniki ( Site 2422)

Thessaloniki, Greece

Rambam Medical Center ( Site 2307)

Haifa, Israel

Edith Wolfson Medical Center ( Site 2306)

Holon, Israel

Hadassah Medical Center. Ein Kerem ( Site 2303)

Jerusalem, Israel

Rabin Medical Center ( Site 2305)

Petah Tikva, Israel

Chaim Sheba Medical Center ( Site 2301)

Ramat Gan, Israel

Istittuto Nazionale dei Tumori Regina Elena IRCCS - IFO ( Site 2121)

Roma, Abruzzo, Italy

Fondazione Policlinico Universitario Agostino Gemelli ( Site 2124)

Rome, Lazio, Italy

Istituto di Candiolo - IRCCS ( Site 2125)

Candiolo, Piedmont, Italy

Azienda Ospedaliera Spedali Civili di Brescia ( Site 2135)

Brescia, Italy

IRCCS Ospedale San Raffaele ( Site 2130)

Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 2122)

Milan, Italy

Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 2132)

Milan, Italy

Azienda Ospedaliera Universitaria Federico II ( Site 2123)

Naples, Italy

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 2127)

Naples, Italy

Istituto Oncologico Veneto IRCCS-Oncologia 2 ( Site 2134)

Padova, Italy

Aichi Cancer Center Hospital ( Site 4190)

Nagoya, Aichi-ken, Japan

National Cancer Center Hospital East ( Site 4197)

Kashiwa, Chiba, Japan

National Hospital Organization Shikoku Cancer Center ( Site 4181)

Matsuyama, Ehime, Japan

Ehime University Hospital ( Site 4187)

Tōon, Ehime, Japan

Kurume University Hospital ( Site 4186)

Kurume, Fukuoka, Japan

Gunma Prefectural Cancer Center ( Site 4183)

Ōta, Gunma, Japan

Hokkaido University Hospital ( Site 4194)

Sapporo, Hokkaido, Japan

Hyogo Cancer Center ( Site 4195)

Akashi, Hyōgo, Japan

Iwate Medical University Hospital ( Site 4189)

Shiwa-gun, Iwate, Japan

University of the Ryukyus Hospital ( Site 4184)

Nakagami-gun, Okinawa, Japan

Saitama Medical University International Medical Center ( Site 4182)

Hidaka, Saitama, Japan

Shizuoka Cancer Center Hospital and Research Institute ( Site 4192)

Sunto-gun, Shizuoka, Japan

National Hospital Organization Kyushu Cancer Center ( Site 4193)

Fukuoka, Japan

Niigata Cancer Center Hospital ( Site 4185)

Niigata, Japan

Osaka International Cancer Institute ( Site 4188)

Osaka, Japan

The Cancer Institute Hospital of JFCR ( Site 4196)

Tokyo, Japan

Keio University Hospital ( Site 4191)

Tokyo, Japan

Investigacion Onco Farmaceutica S de RL de CV ( Site 1127)

La Paz, Baja California Sur, Mexico

Hospital San Lucas Cardiologica del Sureste ( Site 1122)

Tuxtla Gutiérrez, Chiapas, Mexico

Instituto Nacional de Cancerologia ( Site 1124)

Mexico City, Mexico City, Mexico

Christus Muguerza Clinica Vidriera ( Site 1125)

Monterrey, Nuevo León, Mexico

I Can Oncology Center SA de CV ( Site 1126)

Monterrey, Nuevo León, Mexico

Centro Oncologico Internacional. SEDNA ( Site 1121)

Mexico City, Mexico

Hospital Angeles Roma ( Site 1123)

Mexico City, Mexico

University Hospital of North Norway ( Site 2153)

Tromsø, Troms, Norway

Soerlandet sykehus HF Kristiansand ( Site 2152)

Kristiansand, Vest-Agder, Norway

Oslo Universitetssykehus Radiumhospitalet ( Site 2151)

Oslo, Norway

Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 2484)

Poznan, Greater Poland Voivodeship, Poland

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2487)

Siedlce, Masovian Voivodeship, Poland

Szpital Kliniczny im Ks Anny Mazowieckiej ( Site 2481)

Warsaw, Masovian Voivodeship, Poland

Bialostockie Centrum Onkologii ( Site 2483)

Bialystok, Podlaskie Voivodeship, Poland

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2482)

Gliwice, Silesian Voivodeship, Poland

SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2486)

Olsztyn, Warmian-Masurian Voivodeship, Poland

Swietokrzyskie Centrum Onkologii SPZOZ ( Site 2485)

Kielce, Świętokrzyskie Voivodeship, Poland

Arkhangelsk Clinical Oncological Dispensary ( Site 2637)

Arkhangelsk, Arkhangelskaya oblast, Russia

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 2645)

Ufa, Baskortostan, Respublika, Russia

Chelyabinsk Regional Clinical Center Oncology and Nuclear Medicine ( Site 2644)

Chelyabinsk, Chelyabinsk Oblast, Russia

Krasnoyarsk Regional Clinical oncology dispensary ( Site 2643)

Krasnoyarsk, Krasnoyarsk Krai, Russia

National Research Ogarev Mordovia State University ( Site 2648)

Saransk, Mordoviya, Respublika, Russia

FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 2634)

Moscow, Moscow, Russia

Moscow Research Oncology Institute named after P.A. Hertsen ( Site 2631)

Moscow, Moscow, Russia

Nizhegorodsky Regional Oncology Dispensary-chemotherapy department (Branch№1) ( Site 2639)

Nizhny Novgorod, Nizhny Novgorod Oblast, Russia

Samara Regional Clinical Oncology Center-Chemotherapy Dapartment ( Site 2649)

Samara, Samara Oblast, Russia

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 2636)

Saint Petersburg, Sankt-Peterburg, Russia

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2646)

Kazan', Tatarstan, Respublika, Russia

Tomsk Scientific Research Institute of Oncology-Chemotherapy ( Site 2638)

Tomsk, Tomsk Oblast, Russia

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 2641)

Yaroslavl, Yaroslavl Oblast, Russia

National Cancer Center ( Site 4065)

Goyang-si, Kyonggi-do, South Korea

Seoul National University Bundang Hospital ( Site 4063)

Seongnam-si, Kyonggi-do, South Korea

Severance Hospital Yonsei University Health System ( Site 4062)

Seoul, South Korea

Asan Medical Center ( Site 4061)

Seoul, South Korea

Samsung Medical Center ( Site 4064)

Seoul, South Korea

Hospital Josep Trueta ( Site 2184)

Girona, Gerona, Spain

Clinica Universitaria de Navarra ( Site 2181)

Madrid, Madrid, Comunidad de, Spain

Hospital Vall D Hebron ( Site 2182)

Barcelona, Spain

Hospital Clinic i Provincial ( Site 2185)

Barcelona, Spain

Hospital Universitario Reina Sofia ( Site 2183)

Córdoba, Spain

Hospital Clinico San Carlos ( Site 2187)

Madrid, Spain

Hospital Universitario La Paz ( Site 2186)

Madrid, Spain

Karolinska Universitetssjukhuset Solna ( Site 2220)

Solna, Stockholm County, Sweden

Blod-och Tumorsjukdomar ( Site 2221)

Uppsala, Uppsala County, Sweden

Universitetssjukhuset i Linkoping. ( Site 2222)

Linköping, Östergötland County, Sweden

Changhua Christian Hospital ( Site 4095)

Changhua, Taiwan

Taichung Veterans General Hospital ( Site 4094)

Taichung, Taiwan

MacKay Memorial Hospital ( Site 4092)

Taipei, Taiwan

Taipei Veterans General Hospital ( Site 4093)

Taipei, Taiwan

Linkou Chang Gung Memorial Hospital ( Site 4091)

Taoyuan District, Taiwan

Baskent Adana Dr Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 2355)

Adana, Turkey (Türkiye)

Cukurova Uni. Tip Fakultesi ( Site 2353)

Adana, Turkey (Türkiye)

Baskent Universitesi Ankara Hastanesi ( Site 2354)

Ankara, Turkey (Türkiye)

Ankara Universitesi Tıp Fakultesi Hastanesi ( Site 2350)

Ankara, Turkey (Türkiye)

Medipol Universite Hastanesi ( Site 2352)

Istanbul, Turkey (Türkiye)

Ege University Medical Faculty ( Site 2351)

Izmir, Turkey (Türkiye)

I.E.U. Medical Point Hastanesi ( Site 2356)

Izmir, Turkey (Türkiye)

Chernihiv Medical Center of Modern Oncology ( Site 2368)

Chernihiv, Chernihiv Oblast, Ukraine

Municipal Enterprise "Bukovinian сlinical oncology сenter" ( Site 2366)

Chernivtsi, Chernivetska Oblast, Ukraine

SO Grigoriev Institute for Medical Radiology and Oncology of NAMS of Ukraine ( Site 2363)

Kharkiv, Kharkivs’ka Oblast’, Ukraine

MNE "Khmelnytskyi regional antitumor center" ( Site 2365)

Khmelnitskyi, Khmelnytskyi Oblast, Ukraine

LISOD - Israeli Oncological Hospital MedX-ray International Group, LLC ( Site 2364)

Kiev, Kyivska Oblast, Ukraine

Lviv State Regional Oncological Center ( Site 2361)

Lviv, Lviv Oblast, Ukraine

The Municipal Enterprise Volyn Regional Medical Oncology Centre ( Site 2362)

Lutsk, Volyn Oblast, Ukraine

Bristol Haematology and Oncology Centre ( Site 2244)

Bristol, Bristol, City of, United Kingdom

Castle Hill Hospital-Academic Oncology ( Site 2252)

Cottingham, East Riding Of Yorkshire, United Kingdom

Beatson West of Scotland Cancer Centre ( Site 2247)

Glasgow, Glasgow City, United Kingdom

UCLH NHS Foundation Trust ( Site 2242)

London, London, City of, United Kingdom

Royal Marsden NHS Foundation Trust ( Site 2248)

London, London, City of, United Kingdom

Royal Marsden Hospital Sutton-Surrey ( Site 2241)

Sutton, London, City of, United Kingdom

Leicester Royal Infirmary. Univ. Hosp. of Leicester NHS Trust ( Site 2249)

Leicester, United Kingdom

The Christie Hospital NHS Foundation Trust ( Site 2243)

Manchester, United Kingdom